Marie Louise Jakobsen
Overview
Explore the profile of Marie Louise Jakobsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bannister W, Raben D, Valentiner-Branth P, Tolstrup M, Larsen L, Tarp B, et al.
Open Forum Infect Dis
. 2023 Jun;
10(6):ofad248.
PMID: 37351453
Background: Side effects to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are a key concern contributing to vaccine hesitancy, but more individuals may be encouraged if SARS-CoV-2 vaccines were...
2.
Jordans C, Vasylyev M, Rae C, Jakobsen M, Vassilenko A, Dauby N, et al.
Euro Surveill
. 2023 Jan;
27(48).
PMID: 36695464
BackgroundAdequate identification and testing of people at risk for HIV is fundamental for the HIV care continuum. A key strategy to improve timely testing is HIV indicator condition (IC) guided...
3.
Staerke N, Reekie J, Johansen I, Nielsen H, Benfield T, Wiese L, et al.
BMJ Open
. 2022 Dec;
12(12):e069065.
PMID: 36585137
Purpose: The ENFORCE cohort is a national Danish prospective cohort of adults who received a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine as part of the Danish National SARS-CoV-2...
4.
Gasbarrini N, Dubravic D, Combs L, Diskovic A, Ankiersztejn-Bartczak M, Colaiaco F, et al.
BMC Infect Dis
. 2021 Sep;
21(Suppl 2):874.
PMID: 34517819
Background: Maximising access to testing by targeting more than one infection is effective in identifying new infections in settings or populations. Within the EU funded Joint Action INTEGRATE, this paper...
5.
Raben D, Sullivan A, Mocroft A, Kutsyna G, Hadziosmanovic V, Vassilenko A, et al.
PLoS One
. 2019 Aug;
14(8):e0220108.
PMID: 31408476
Background: It is cost-effective to perform an HIV test in people with specific indicator conditions (IC) with an undiagnosed HIV prevalence of at least 0.1%. Our aim was to determine...
6.
Fabiansen C, Jakobsen M, Thybo S
Ugeskr Laeger
. 2016 Jan;
177(2):V66468.
PMID: 26750195
No abstract available.